“The pharmacological substance basis and mechanism of action of Qinlian Jiangxia Tang in treating glucose and lipid metabolism disorders have been verified by the research team based on network pharmacology and cell experiments. The regulatory mechanism of FABP4/PPARG signaling pathway has been explored, opening up new directions for the study of traditional Chinese medicine in the treatment of metabolic diseases.”